← Back
Data updated: Mar 29, 2026
AJANTA PHARMA LTD
NeurologyCardiovascularInfectious Disease
Generics
AJANTA PHARMA LTD is a generic drug manufacturer focused on Neurology, Cardiovascular, Infectious Disease.
2011
Since
60
Drugs
-
Trials
787
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 28%
5 drugs
Cardiovascular 28%
5 drugs
Infectious Disease 17%
3 drugs
Gastroenterology 17%
3 drugs
Ophthalmology 11%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Cardiovascular, Ophthalmology
AbbVie big-pharma
Neurology, Infectious Disease, Ophthalmology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
B BRAUN specialty
Infectious Disease, Ophthalmology, Cardiovascular
Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease, Neurology
Active (35)
VARENICLINE TARTRATE NAPROXEN AND ESOMEPRAZOLE MAGNESIUM TADALAFIL SILODOSIN OSELTAMIVIR PHOSPHATE TETRABENAZINE PALIPERIDONE ALMOTRIPTAN MALATE ARIPIPRAZOLE SOLIFENACIN SUCCINATE RANOLAZINE ZOLMITRIPTAN ENTACAPONE IRBESARTAN OMEPRAZOLE AND SODIUM BICARBONATE VORICONAZOLE LANSOPRAZOLE DIVALPROEX SODIUM OXCARBAZEPINE PANTOPRAZOLE SODIUM VENLAFAXINE HYDROCHLORIDE LAMOTRIGINE TOPIRAMATE FAMOTIDINE FLUVOXAMINE MALEATE RANITIDINE HYDROCHLORIDE CHOLESTYRAMINE PROCHLORPERAZINE MALEATE CLOMIPRAMINE HYDROCHLORIDE GUANFACINE HYDROCHLORIDE METHAZOLAMIDE CARBAMAZEPINE ACETAZOLAMIDE DOXYCYCLINE HYCLATE DOXEPIN HYDROCHLORIDE
Discontinued (21)
TOFACITINIB CITRATE OLANZAPINE PRUCALOPRIDE SUCCINATE FENOFIBRATE FLUPHENAZINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE RISPERIDONE MONTELUKAST SODIUM MEMANTINE HYDROCHLORIDE TOLTERODINE TARTRATE THEOPHYLLINE FENOFIBRATE (MICRONIZED) TERAZOSIN HYDROCHLORIDE AMLODIPINE AND OLMESARTAN MEDOXOMIL VALGANCICLOVIR HYDROCHLORIDE DULOXETINE HYDROCHLORIDE BREXPIPRAZOLE CLONIDINE HYDROCHLORIDE CHLORTHALIDONE CAPTOPRIL OXYBUTYNIN CHLORIDE
Company Info
- First Approval
- 2011-08-24
- Latest
- 2026-02-18
- Applications
- 77